Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116421) titled 'Effect of Rose Odor Exposure on Ictal Apnea' on Aug. 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Prevention. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Vanderbilt University Medical Center
Condition:
Epilepsy
Sudden Unexpected Death in Epilepsy
Intervention:
Drug: 2-phenylethanol rose scent
Recruitment Status: Recruiting
Phase: Early Phase 1
Date of First Enrollment: July 1, 2025
Target Sample Size: 40
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show...